Within biotechnology, the production of recombinant proteins in various prokaryotic and eukaryotic expression systems represents a mature and attractive technological field with high employability. It is also a very important area of research in which many challenges remain to be addressed. The bioproduction of biomedicines (recombinant proteins as well as monoclonal antibodies) represents a major challenge in human therapeutics, but also in many areas of biotechnology (environmental, industrial, agronomic, marine, etc.). Before designing any biological drug involving a bioproduction stage, it is essential to understand the different eukaryotic and prokaryotic expression systems used in biotechnology and to have a comprehensive overview of the landscape and challenges of bioproduction in France, Europe, and around the world.
This course unit includes interactive lectures. It is taught by various academic and industry experts involved in the field.
